SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-124988
Filing Date
2023-12-11
Accepted
2023-12-11 16:05:43
Documents
3
Period of Report
2023-12-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2332623d1_6k.htm 6-K 9062
2 EXHIBIT 99.1 tm2332623d1_ex99-1.htm EX-99.1 9994
3 GRAPHIC tm2332623d1_ex99-1img001.jpg GRAPHIC 2090
  Complete submission text file 0001104659-23-124988.txt   23081
Mailing Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22
Business Address KUNGSBRON 1, D5 STOCKHOLM V7 SE-111 22 46 8411 3005
Calliditas Therapeutics AB (Filer) CIK: 0001795579 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39308 | Film No.: 231478165
SIC: 2834 Pharmaceutical Preparations